Q3 2019 Biosyent Inc Earnings Call Transcript
© -
Hello. Welcome to the BioSyent Q3 2019 Results Presentation. My name is René Goehrum, and I'm the President and CEO of BioSyent Inc.
I'm going to start today's presentation with a look at our quarter sales and profitability. So in the period ended September 30, our revenue hit $6.22 million, that was up 18% versus year ago. So the thing to note here is that $1 million of revenue was generated from FeraMAX customers outside of Canada. So we had reported in the past that we had somewhat of a backlog because of issues around import permits by our customer -- our largest customer. And so that backlog was shipped and -- to the end of September. And so that was $1 million of revenue essentially piled into 1 quarter and obviously had a positive impact on the quarter sales, and that trickled down through to both EBITDA and NIAT EBITDA up 15% to just under $2 million for the quarter and net income after tax at $1.53 million, up 21% versus a year ago. So this quarter represented our 37th consecutive profitable quarter.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
